Cambios en parámetros metabólicos e inflamatorios en un paciente diabético tipo 1 realizando actividades extremas by Alonso, Natalia et al.
Nutrición
Hospitalaria
Nota Clínica 
ISSN (electrónico): 1699-5198 - ISSN (papel): 0212-1611 - CODEN NUHOEQ S.V.R. 318
Correspondence: 
Enrique Roche. Instituto de Bioingeniería. Universidad 
Miguel Hernández. Av. de la Universidad. 03202 Elche, 
Spain
e-mail: eroche@umh.es
Alonso N, Martínez-Peinado P, Pascual-García S, Sempere JM, Roche E. Changes in metabolic 
and inflammatory parameters in a type 1 diabetic patient performing extreme activities. Nutr Hosp 
2019;36(2):487-491
DOI: http://dx.doi.org/10.20960/nh.2334
Changes in metabolic and inflammatory parameters in a type 1 diabetic patient 
performing extreme activities
Cambios en parámetros metabólicos e inflamatorios en un paciente diabético tipo 1 realizando 
actividades extremas
Natalia Alonso1, Pascual Martínez-Peinado2, Sandra Pascual-García2, José M. Sempere2 and Enrique Roche1,3,4
1Biochemistry and Cell Therapy Unit. Institute of Bioengineering. Universidad Miguel Hernández. Elche, Alicante. Spain. 2Department of Biotechnology. Universidad de 
Alicante. Alicante, Spain. 3CIBERobn (Fisiopatología de la Obesidad y la Nutrición CB12/03/30038). Instituto de Salud Carlos III. Madrid, Spain. 4Department of Applied 
Biology-Nutrition. Universidad Miguel Hernández. Alicante, Spain. Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation). Alicante, Spain
Palabras clave: 
Citocinas. Alpinista 
diabético. Astronauta 
diabético. Situación 
extrema. Estrés. 
Resumen
Introducción: la actividad física en pacientes diabéticos tipo 1 permite un mejor control de la glucemia y hemoglobina glucosilada, ayuda a 
mantener una masa residual de páncreas endocrino y optimiza las necesidades de insulina. Estas mejoras podrían ser debidas en parte al incre-
mento en citocinas antiinflamatorias que ayudarían a minimizar la destrucción de células β. Sin embargo, el tipo, la intensidad y la frecuencia 
de ejercicio para pacientes diabéticos tipo 1 no han sido establecidos.
Caso clínico: presentamos el caso de un varón de 48 años de edad diagnosticado de diabetes tipo 1 a los 23. Es alpinista profesional y 
recientemente ha sido reclutado por el Centro de Entrenamiento para Cosmonautas Yuri Gagarin (Rusia) para ser el primer astronauta diabético. 
Hemos comparado respuestas metabólicas e inflamatorias tras realizar dos actividades extremas.
Discusión: actividades extremas bien programadas y con una correcta intervención dietética pueden reducir la descompensación metabólica 
e inflamatoria causada por la combinación actividad-enfermedad.
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Abstract
Background: physical activity in type 1 diabetic patients allows a better control of glycaemia and glycosylated hemoglobin, helps to maintain a 
residual endocrine pancreatic mass and optimizes subsequent insulin requirements. These improvements might be due in part to increases in 
anti-inflammatory cytokines that could help to minimize β-cell destruction. However, type, intensity and frequency of exercise for type 1 diabetic 
patients remain to be established.
Case report: we present the case of a 48-year-old man diagnosed with type 1 diabetes at the age of 23. He is a professional alpinist and recently 
was recruited in a program of the Yuri Gagarin Cosmonaut Training Center (Russia) to be the first diabetic astronaut. Metabolic and inflammatory 
responses were assessed after performing two extreme activities.
Discussion: well programmed extreme activities accompanied by a correct dietetic intervention can reduce the adverse metabolic and inflam-
matory processes that appear due to exercise and diabetes.
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INTRODUCTION
It is well known that physical activity has beneficial effects on 
an individual’s overall health. In this respect, physical exercise as 
part of their regular habits in individuals with type 1 diabetes has 
the potential to help them manage their disease more efficiently 
(1). Type 1 diabetes is an autoimmune disease in which pancreatic 
β-cells are destroyed, forcing the patients to inject themselves 
insulin for the rest of their lives (2). Very often, patients diagnosed 
with type 1 diabetes tend to be less physically active than healthy 
people. Fear to disease, management of glycaemia and risk to 
suffer hypoglycemic episodes are the main obstacles that type 1 
diabetic patients must face when performing physical activity 
(3). This situation of inactivity favors the development of cardio-
vascular disease, overweight and joint pain, as well as the early 
appearance of diabetic complications (1,3). Fortunately, recent 
new technological advances allow patients to continuously monitor 
their glucose levels and optimize insulin intake, allowing diabetic 
patients to better manage their disease and perform with no risk 
physical activity (4).
Active type 1 diabetic patients present a decrease in glycosylat-
ed hemoglobin, post-exercise and post-prandial glycaemia, result-
ing in a reduction of injected insulin (5). Since the development of 
microvascular complications (i.e., retinopathy and nephropathy) 
are strongly related to glycemic control, exercise might delay the 
onset of diabetic complications (1). Nowadays, recent research 
has underlined the role of physical activity in the modulation of 
the immune and inflammatory response. Physical activity leads to 
a reduction in immunoglobulin secretion and modifies the balance 
between Th1/Th2 lymphocytes in favor of Th2 cells that secrete 
interleukin-10 (IL-10) compensating the inflammatory status 
caused by the disease (6). Altogether, the beneficial potential of 
physical activity in the control of type 1 diabetes seems to go 
beyond the mimetic effect of injected insulin, considering immu-
nomodulation and anti-inflammation as new aspects to study.
Nevertheless, an intense area of research concerns the 
type, intensity and frequency of physical activity that each type 
1 diabetic patient should perform in order to potentiate all the 
above-mentioned benefits. The majority of the studies support the 
idea that aerobic exercise in combination with resistance routines 
contributes to optimal reduction of glycosylated hemoglobin and 
improved glycemic control (7,8). In this sense, it is recommend-
ed to exercise 150 min/week in five sessions, at an intensity 
of 40-85% VO
2
max or 55-90% maximal cardiac frequency. The 
protocol in each session includes 5-10 minutes of warm-up at 
the beginning, followed by the activity itself and 5-10 minutes of 
stretching at the end (9). Recently, high intensity interval training 
has been shown to exert similar benefits because it carries out a 
similar energetic expenditure than endurance exercises but in a 
shorter period of time (10).
However, a common limitation in the majority of the published 
studies regarding physical activity and diabetes management is 
the low number of participants (7,8). The result of such a limita-
tion is that there is no clear consensus as to the recommended 
types of activities or sports for type 1 diabetic patients. Recent-
ly, the performance of sports practice in extreme environmental 
conditions has risen in popularity. Therefore, the objective of this 
study is to analyze the metabolic and inflammatory changes that 
a type 1 diabetic patient suffered after completing two extreme 
challenges. These include the exposure to a high altitude during 
an alpine expedition to the Himalaya and the performance of the 
physical probes that astronauts undergo for their specific prepa-
ration to go to outer space, such as acceleration, piloting and 
microgravity tests.
CASE REPORT
A 48-year-old male (165 cm height and 69 kg weight) partic-
ipated in the study and gave his informed written consent. The 
intervention was approved by the Ethics Committee of Miguel Her-
nandez University (Elche, Spain) and met the legal requirements 
stated in the Declaration of Helsinki for research on human beings. 
Ten years before the intervention, the subject was a professional 
alpinist sponsored by different pharmaceutical companies being 
the first type 1 diabetic person that performed the circuit of the 
seven summits and reaching both poles (www.josufeijoo.com). 
During this period, the subject was very often exposed to extreme 
environmental conditions of temperature, partial oxygen pressure 
and physical and psychological stress. He prepared the different 
expeditions performing mainly aerobic activities consisting in long 
distance races and cycling. He declared that during mountain 
expeditions he did not follow a highly specific dietetic plan due to 
the difficulty to carry certain foods during ascensions.
Due to his abilities to perform tasks in extreme environments, he 
was recruited to participate in a program in the Yuri Gagarin Cos-
monaut Training Center (Russia) to develop and investigate in new 
devices for telemedicine, particularly those with utilities in space 
missions. Thanks to this new project, he was the first type 1 diabetic 
astronaut in history. From this moment, diet and training routines 
were under supervision.
During training days, he performed a session of road cycling 
in the morning (1.5 h) and weight lifting (60-70% of the maximal 
weight lifted in only one repetition) in the afternoon (1 h). One day 
a week, he performed a surf training session in the beach (2 h) fol-
lowed by a core training session (45 min) in the afternoon. The train-
ing protocol changed in certain weeks to avoid monotony, including 
long distance running (2 h), mountain cycling (2 h) or hiking (4 h) in 
the morning, followed by core training (45 min) in the evening. One 
day a week was for resting. His diet during training days consisted in 
2,400-2,600 kcal, rich in carbohydrates (60-65%), 25-30% lipids 
and 10% proteins. The exercise was performed when glycaemia 
reached 180-200 mg/dl in order to avoid hypoglycemia episodes 
during exercise performance. Daily glycaemia was controlled by a 
long-acting insulin injection early in the morning and the injection 
of 3-4 units of immediate-acting insulin before exercise, according 
to the level of glycaemia. During the resting days, a 1,700 kcal diet 
was taken, consisting in 55% carbohydrates, 30% lipids and 15% 
proteins. Diet consumption was distributed in five daily intakes with 
two intakes after the two training sessions.
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The objective of the intervention consisted in comparing the 
circulating metabolic and inflammatory parameters after a 22-day 
mountain expedition trek to the Everest camp base (5,364 m) and 
after different probes (6xg acceleration, microgravity and piloting) 
performed at the Yuri Gagarin Cosmonaut Training Center (Russia) 
the same year. Before both missions, a constant treadmill test was 
performed, consisting in 45 min running at 8-10 km/h. Glycaemia 
was monitored six times during the test at the beginning, three 
minutes, 13 minutes, 24 minutes, 36 minutes and at the end. 
Towards the end of the test, the speed slowed down to 4.8 km/h 
(passing from running to walking), allowing a correct manipulation 
of the subject for finger puncture during one minute, approxi-
mately. Initial glycaemia was 180 mg/dl at the beginning and 
descended gradually to 141 mg/dl at the end of the test. Cardiac 
frequency oscillated between 170-200 beats/min and the VO
2
max 
was 48.7 ml/kg/min, considered to be optimal regarding the age 
and pathophysiological characteristics of the subject. Altogether, 
he was considered to be in the 90th percentile according to the 
criteria of the American College of Sport Medicine. During both 
challenges, the subject tried to maintain a stable glycaemia by 
eating certain supplements in specific moments in combination 
with insulin injections. The reported glycaemia during the alpine 
expedition oscillated between 110-140 mg/dl. Using a similar 
strategy during the different tests in the Cosmonaut Training 
Center, glycaemia oscillated between 122-145 mg/dl. No epi-
sodes of hypoglycemia were reported during both activities. In 
addition, the subject was conscious during the 45 minutes of the 
acceleration and piloting tests. 
A total of three blood extractions were performed in fasting con-
ditions. One extraction was performed the morning after a training 
day in order to monitor regular circulating parameters during the 
training period. The second extraction was performed after landing 
from the mountain expedition (seven days after reaching the base 
camp of the Everest). The third extraction was performed seven 
days after finishing the probes in the Cosmonaut Training Center. It 
is important to mention that we could not make the extraction just 
after finishing the extreme activities and for this reason several 
parameters presented a partial recovery that has to be taken into 
account during the interpretation of the results.
Regarding circulating cellular parameters (Table I), they all were 
in the healthy range. Only an increase in hematocrit was observed 
after the mountain expedition, coinciding with an increase in eryth-
rocyte number. This could be due to the hypoxia undergone by 
the subject during the exposure to altitude as we have previously 
observed in healthy individuals (11). Regarding leucocytes, an 
increase in the number of neutrophils was observed only after the 
mountain expedition, coinciding with increased platelet number. 
This increase was not noticed after the probes in the Cosmonaut 
Training Center. Our interpretation is that the mountain expedition 
could be experienced as a stress situation by the subject that is 
better controlled during the probes in the Cosmonaut Training 
Center.
Regarding circulating biochemical parameters (Table II), gly-
caemia increased after the mountain expedition, coinciding with 
an increase in glycosylated hemoglobin. A higher glycaemia was 
observed after the probes in the Cosmonaut Training Center but 
was not accompanied by an increase in glycosylated hemoglobin. 
Therefore, this change was interpreted as a punctual anomaly 
during the moment of extraction. Regarding the lipid profile, the 
subject presents high levels of total cholesterol and triglycerides 
after both activities. Since the levels of HDL and LDL were in 
the healthy ranges, these results were interpreted as a conse-
quence of the diet during the return trip and after completing the 
objectives. In addition, GPT and GGT increased slightly after the 
mountain expedition. CK was elevated as well, indicating a certain 
level of muscle damage, but this occurs very often in people mak-
ing intense physical activity. Finally, plasmatic protein carbonyls 
were elevated after the mountain expedition due to the increased 
oxidative stress that involves the exposure to extreme altitude, as 
Table I. Cellular circulating parameters 
determined in a regular training  
day (training), after the mountain 
expedition (post-mountain) and after the 
probes in the Cosmonaut Training Center 
(post-probes)
Parameters 
(units)
Training
Post-
mountain
Post-probes
Erythrocytes 
(x106/mm3)
5.3 5.6 5.2
Hemoglobin 
(g/dl)
16.2 16 15.5
Hematocrit (%) 47.2 49.4 45.3
MCV (fl) 89 88.5 87
MCH (pg) 30.5 28.6 29.8
MCHC (g/dl) 34.2 32.4 34.2
RDW (%) 12.4 13.7 14.2
Leucocytes 
(x103/mm3)
5.4 7 5.7
Neutrophils 
(x103/mm3)
3.1 4.4 3.0
Lymphocytes 
(x103/mm3)
1.6 1.8 2.1
Monocytes 
(x103/mm3)
0.5 0.6 0.3
Eosinophils 
(x103/mm3)
0.1 0.2 0.2
Basophils  
(x103/mm3)
0.1 0.1 0.1
Platelets  
(x103/mm3)
278 359 262
MPV(fl) 8.4 9.2 9.2
MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin 
concentration; MCV: mean corpuscular volume; MPV: mean platelet volume; 
RDW: red blood cell distribution width.
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observed previously (11). The remaining circulating parameters 
were considered to be in the healthy range.
Regarding the cytokines (Table III), pro-inflammatory cytokines 
(IL-1β, IL-12p70, IFN-γ and TNF-α) were elevated during the 
training period, with the exception of IL-17a. A similar effect was 
observed in a previous report, in diabetic participants when exer-
cising compared to type 1 diabetic sedentary volunteers (12). 
However, in the same study, the anti-inflammatory cytokines were 
elevated, most likely compensating the effect of the pro-inflamma-
tory cytokines, while sedentary type 1 diabetic subjects presented 
lower levels of the anti-inflammatory cytokines IL-10, IL-13 and 
IL-22 (12). The diabetic astronaut presented a very similar pattern 
with high increases of IL-10, IL-13 and IL-22 after finishing both 
extreme activities, suggesting an optimal adaptation to the stress.
DISCUSSION
The subject studied in the present case declared often decom-
pensations in glycaemia and in glycosylated hemoglobin in the 
period he was a professional alpinist. The entry in the Yuri Gagarin 
Cosmonaut Training Center program and the optimization of diet 
and training allowed to a better adaptation to extreme activities 
despite the disease. This is reflected by a correct control of gly-
caemia during the activities and the subsequent increase in cir-
culating anti-inflammatory cytokines when both challenges were 
finished (Table III). Since blood extractions were not performed 
immediately after the execution of both activities, it was not pos-
sible to determine exactly the inflammatory status immediately 
after each challenge. We hypothesize a likely increase of pro-in-
flammatory cytokines, as observed during the training period. It 
must be mentioned that the subject generally performs physical 
activity in a hyperglycemic state and this stress could be activat-
ing pro-inflammatory cytokines. However, this stress is quickly 
Table II. Biochemical circulating 
parameters determined in a regular 
training day (training), after the mountain 
expedition (post-mountain) and after the 
probes in the Cosmonaut Training Center 
(post-probes)
Parameters 
(units)
Training
Post-
mountain
Post-probes
Glucose (mg/dl) 94 98 109
HbA1c (%) 8.7 9.1 8.5
Cholesterol 
(mg/dl)
195 211 230
HDL cholesterol 
(mg/dl)
86 70 79
LDL cholesterol 
(mg/dl)
95 100 94
Triglycerides 
(mg/dl)
71 209 283
Uric acid  
(mg/dl)
3.2 3.8 4.1
Creatinine  
(mg/dl)
0.83 0.73 0.73
Urea (mg/dl) 30 26 33
GOT/AST (U/l) 35 30 30
GPT/ALT (U/l) 29 45 37
GGT (U/l) 41 45 37
Alkaline 
phosphatase 
(U/l)
89 105 90
CK (U/l) 283 240 222
Iron (µg/dl) 68 64 71
Ferritin (ng/dl) 66 63 23
Na+ (mmol/l) 146 145 138
K+ (mmol/l) 4.8 5.3 4.2
Myoglobin (µg/l) 30.2 26.0 31.2
Lactate (mg/dl) 12 15 15
Protein 
carbonyls 
(µmols/l)
65,27 87.49 57.46
CK: creatine kinase; GGT: γ-glutamyl transpeptidase; GOT /AST: glutamate-
oxaloacetate transaminase/aspartate transaminase; GPT/ALT: glutamate-
piruvate transaminase/alanine aminotransferase; HbA1c: glycosylated 
hemoglobin.
Table III. Circulating cytokines determined 
in a regular training day (training), after 
the mountain expedition (post-mountain) 
and after the probes in the Cosmonaut 
Training Center (post-probes)
Cytokines 
(ng/ml)
Training
Post-
mountain
Post-
probes
IL-1β 13.23 3.71 3.71
IL-9 nd nd nd
IL-12p70 0.86 0.39 0.11
IL-17a 0.34 0.49 0.40
IFN-γ 5.12 3.55 2.07
TNF-α 7.95 5.84 5.07
IL-2 22.33 12.52 10.09
IL-4 9.77 8.76 8.98
IL-5 0.10 0.20 0.33
IL-10 nd 0.19 0.87
IL-13 10.01 9.42 10.00
IL-22 120.16 269.06 277.43
IFN: interferon; IL: interleukin; nd: non detected; TNF: tumor necrosis factor. 
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compensated by the activation of an anti-inflammatory response, 
to which diet and training routine should contribute. In any case, 
this is a question that needs further investigation. In conclusion, 
extreme activities could be performed by type 1 diabetic subjects, 
but under a strict control of diet and training in order to favor an 
anti-inflammatory response. Nevertheless, this is a case report, 
and data interpretation must be made with extreme caution.
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